BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Wachter S, Knowles CH, Elterman DS, Kennelly MJ, Lehur PA, Matzel KE, Engelberg S, Van Kerrebroeck PEV. New Technologies and Applications in Sacral Neuromodulation: An Update. Adv Ther 2020;37:637-43. [PMID: 31875299 DOI: 10.1007/s12325-019-01205-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Duchalais E, Drissi F, Delestre M, Wyart V, Lehur PA, Meurette G. Long-term results of sacral neuromodulation for the treatment of anorectal diseases. J Visc Surg 2021:S1878-7886(21)00147-8. [PMID: 34736877 DOI: 10.1016/j.jviscsurg.2021.09.007] [Reference Citation Analysis]
2 Heidler S, Ostermann S, Kuglitsch M, Sekic F, Wimpissinger F, Lusuardi L, Dietersdorfer F. Multiple magnetic resonance imaging in patients with implanted sacral nerve stimulator. Neurourol Urodyn 2020;39:2368-72. [PMID: 32886804 DOI: 10.1002/nau.24496] [Reference Citation Analysis]
3 Szymański JK, Słabuszewska-Jóźwiak A, Jakiel G. Fowler's Syndrome-The Cause of Urinary Retention in Young Women, Often Forgotten, but Significant and Challenging to Treat. Int J Environ Res Public Health 2021;18:3310. [PMID: 33806865 DOI: 10.3390/ijerph18063310] [Reference Citation Analysis]
4 Bing S, Chawang K, Chiao JC. A Resonant Coupler for Subcutaneous Implant. Sensors (Basel) 2021;21:8141. [PMID: 34884144 DOI: 10.3390/s21238141] [Reference Citation Analysis]
5 Liao L, Zhou Z, Chen G, Xu Z, Huang B, Chong T, Chen Q, Wei Z, Shen B, Chen Z, Ling Q, Weng Z, Jiang H, Shi B, Li Y, Wang Y. Sacral Neuromodulation Using a Novel Device with a Six-contact-point Electrode for the Treatment of Patients with Refractory Overactive Bladder: A Multicenter, Randomized, Single-blind, Parallel-control Clinical Trial. Eur Urol Focus 2022:S2405-4569(22)00083-9. [PMID: 35525837 DOI: 10.1016/j.euf.2022.04.006] [Reference Citation Analysis]
6 Averbeck MA, Moreno-Palacios J, Aparicio A. Is there a role for sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction? Int Braz J Urol 2020;46:891-901. [PMID: 32758301 DOI: 10.1590/S1677-5538.IBJU.2020.99.10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
7 Pericolini M, Miget G, Hentzen C, Finazzi Agrò E, Chesnel C, Lagnau P, Haddad R, Grasland M, Amarenco G. Cortical, Spinal, Sacral, and Peripheral Neuromodulations as Therapeutic Approaches for the Treatment of Lower Urinary Tract Symptoms in Multiple Sclerosis Patients: A Review. Neuromodulation 2021. [PMID: 34496454 DOI: 10.1111/ner.13525] [Reference Citation Analysis]
8 Tilborghs S, De Wachter S. Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects. Expert Review of Medical Devices. [DOI: 10.1080/17434440.2022.2032655] [Reference Citation Analysis]
9 van Ophoven A, Engelberg S, Lilley H, Sievert KD. Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dysfunction (nLUTD): Over 20 Years' Experience and Future Directions. Adv Ther 2021;38:1987-2006. [PMID: 33713279 DOI: 10.1007/s12325-021-01650-9] [Reference Citation Analysis]
10 Karrer-Warzinek E, Abt D, Kim OC, Schmid HP, Engeler DS, Müllhaupt G. Safety of Magnetic Resonance Imaging in patients under Sacral Neuromodulation with an InterStim Neuromodulator. Urology 2021;154:115-9. [PMID: 33774042 DOI: 10.1016/j.urology.2021.03.013] [Reference Citation Analysis]
11 Kaaki B, Gupta D. Medium-term outcomes of sacral neuromodulation in patients with refractory overactive bladder: A retrospective single-institution study. PLoS One 2020;15:e0235961. [PMID: 32645082 DOI: 10.1371/journal.pone.0235961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Pezzella A, McCrery R, Lane F, Benson K, Taylor C, Padron O, Blok B, de Wachter S, Gruenenfelder J, Pakzad M, Perrouin-Verbe MA, van Kerrebroeck P, Mangel J, Peters K, Kennelly M, Shapiro A, Lee U, Comiter C, Mueller M, Goldman HB. Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system. Neurourol Urodyn 2021;40:714-21. [PMID: 33508155 DOI: 10.1002/nau.24615] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
13 Kim Y, Ortega M, Von Bargen E. Updates in treating fecal incontinence in women. Curr Opin Obstet Gynecol 2020;32:461-7. [PMID: 32925257 DOI: 10.1097/GCO.0000000000000660] [Reference Citation Analysis]